Cardiogenetic screening of first-degree relatives after sudden cardiac death in the young: a population-based

Anneke Hendrix1, C Jan Willem Borleffs, Aryan Vink

  • 1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands. a.hendrix@umcutrecht.nl

Insights

Cardiogenetic screening of relatives of sudden cardiac death (SCD) and sudden unexplained death (SUD) victims yielded a 14% diagnosis rate for inherited heart conditions. This highlights a need for systematic screening approaches in population-based settings.

Area of Science:

  • Cardiology
  • Genetics
  • Public Health

Background:

  • Sudden cardiac death (SCD) and sudden unexplained death (SUD) in young individuals often have genetic underpinnings.
  • Family screening is crucial for identifying inherited cardiac conditions and preventing future events.
  • Current population-based screening practices for relatives of SCD/SUD victims may be suboptimal.

Purpose of the Study:

  • To evaluate the diagnostic yield of cardiogenetic screening in first-degree relatives of young SCD/SUD victims.
  • To assess the effectiveness of a population-based approach to family screening after sudden cardiac events.

Main Methods:

  • A population-based study reviewed SCD/SUD cases (ages 1-40) from 2000-2006.
  • Autopsy and cardiogenetic screening data for victims and their first-degree relatives were collected.
  • Relatives without prior screening were invited for additional cardiogenetic evaluation.

Main Results:

  • The study identified 16 SCD/SUD cases and 4 aborted SCD/SUD cases.
  • Common causes included myocardial infarction, arrhythmogenic right ventricular cardiomyopathy (ARVC), and hypertrophic cardiomyopathy.
  • Screening 37 relatives of 12 victims identified Brugada syndrome in 3 and suspected ARVC in 2, yielding a 14% detection rate.

Conclusions:

  • A significant proportion of relatives of SCD/SUD victims are not referred for cardiogenetic screening.
  • Systematic screening approaches are needed to improve the detection of inherited cardiac diseases.
  • The yield of cardiogenetic screening in this population, while substantial, was lower than anticipated.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...